![](/img/cover-not-exists.png)
Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer
Rupert Bartsch, Catharina De Vries, Ursula Pluschnig, Peter Dubsky, Zsuzsanna Bago-Horvath, Simon P Gampenrieder, Margaretha Rudas, Robert M Mader, Andrea Rottenfusser, Christoph Wiltschke, Michael GnVolume:
9
Language:
english
DOI:
10.1186/1471-2407-9-367
Date:
December, 2009
File:
PDF, 644 KB
english, 2009